The U.S. Court of Appeals ruled in favor of lifting a DEA suspension on sales at two CVS pharmacies in Florida.
The DEA had ordered the two CVS locations to stop selling potentially addictive painkillers in February, claiming that the pharmacies were inappropriately filling prescriptions of oxycodone and other controlled substances. The DEA is now battling prescription drug abuse, which today eclipses abuse of most illicit drugs including heroin and cocaine. About 7 million Americans abuse pharmaceuticals made with controlled substances. Florida is the epicenter of this growing epidemic.
A federal district court judge initially blocked the DEA’s request, but then agreed to let it take effect on Tuesday. CVS appealed the decision, arguing that the DEA had acted in an “arbitrary and capricious manner.” CVS said that the company had stopped oxycodone sales at the two pharmacies, a sufficient step to eliminate any immediate danger to the community. However, a Justice Department attorney claimed that suspicious sales had involved other controlled substances.
On Wednesday, the court granted CVS’s appeal, a ruling that will be executed pending further proceedings.
Do you agree with the court’s decision?